SCP — Scope Fluidics SA Share Price
- PLN448.14m
- PLN386.67m
- PLN0.52m
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 7.35 | ||
Price to Tang. Book | 8.24 | ||
Price to Free Cashflow | n/a | ||
Price to Sales | 3,765.91 | ||
EV to EBITDA | n/a |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | -44.27% | ||
Return on Equity | -37.27% | ||
Operating Margin | -27373.11% |
Financial Summary
Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | PLNm | n/a | n/a | n/a | 0.4 | 0.52 | n/a | n/a | n/a |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Scope Fluidics SA is a Poland-based company engaged in the biotechnology. The Company focuses on diagnostic and med-tech solutions. It develops disposable microfluidic systems for the collection of micro-samples of blood, as well as storage of reagents for diagnostic markers. Its projects include PCR ONE system that delivers the bacterial and viral pathogen detection, and BacterOMIC system that delivers information on bacterial susceptibility to antibiotics and on the resistance mechanisms. The Company provides access to laboratories and workshops for developed projects, as well as administrative facilities and services, including financing. In addition, it cooperates with doctors, medical personnel, project managers, engineers and academics.
Directors
- Last Annual
- December 31st, 2023
- Last Interim
- September 30th, 2024
- Incorporated
- March 27th, 2017
- Public Since
- August 16th, 2017
- No. of Employees
- 40
- Sector
- Biotechnology & Medical Research
- Industry
- Healthcare
- Exchange
Warsaw Stock Exchange
- Shares in Issue
- 2,725,930

- Address
- ul. Ogrodowa 58, 9 pietro, WARSZAWA, 00-876
- Web
- https://scopefluidics.com/
- Phone
- +48 223762114
- Auditors
- CSWP Audyt Sp. z o.o.
Upcoming Events for SCP
Similar to SCP
Bioton SA
Warsaw Stock Exchange
Braster SA
Warsaw Stock Exchange
Captor Therapeutics SA
Warsaw Stock Exchange
Genomed SA
Warsaw Stock Exchange
Genomtec SA
Warsaw Stock Exchange
FAQ
As of Today at 23:07 UTC, shares in Scope Fluidics SA are trading at PLN164.40. This share price information is delayed by 15 minutes.
Shares in Scope Fluidics SA last closed at PLN164.40 and the price had moved by -0.84% over the past 365 days. In terms of relative price strength the Scope Fluidics SA share price has underperformed the FTSE Global All Cap Index by -3.32% over the past year.
There is no consensus recommendation for this security.
Find out moreScope Fluidics SA does not currently pay a dividend.
Scope Fluidics SA does not currently pay a dividend.
Scope Fluidics SA does not currently pay a dividend.
To buy shares in Scope Fluidics SA you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of PLN164.40, shares in Scope Fluidics SA had a market capitalisation of PLN448.14m.
Here are the trading details for Scope Fluidics SA:
- Country of listing: Poland
- Exchange: WSE
- Ticker Symbol: SCP
Based on an overall assessment of its quality, value and momentum Scope Fluidics SA is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Scope Fluidics SA. Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -2.03%.
As of the last closing price of PLN164.40, shares in Scope Fluidics SA were trading -2.39% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Scope Fluidics SA PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at PLN164.40.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Scope Fluidics SA's directors